Macrophages in anti-TNF treated IBD patients display increased autophagy activity concomitant with “M2-like” anti-inflammatory features, but this effect is impaired by the ATG16L1 T300A variant434. The gene discussed is ATG16L1; the disease is inflammatory bowel disease.